Health Care [ 3/12 ] | Biotechnology [ 25/74 ]
NASDAQ | Common Stock
Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics.
It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease.
The company was founded in 2020 and is based in San Diego, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 7, 24 | -0.84 Decreased by -100.00% | -2.84 Increased by +70.42% |
| Aug 9, 24 | -5.13 Decreased by -1.95 K% | -1.80 Decreased by -185.00% |
| May 10, 24 | -2.46 Decreased by -188.17% | -5.38 Increased by +54.28% |
| Mar 22, 24 | -8.33 Decreased by -392.90% | -13.77 Increased by +39.51% |
| Nov 9, 23 | -0.42 Increased by +80.00% | -0.30 Decreased by -40.00% |
| Aug 11, 23 | -0.25 Increased by +94.05% | -0.40 Increased by +37.50% |
| May 22, 23 | 2.79 Increased by +116.96% | -0.65 Increased by +529.23% |
| Mar 30, 23 | -1.69 Increased by +98.90% | -1.75 Increased by +3.43% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | N/A Decreased by N/A% | -2.24 M Increased by +14.72% | - - |
| Jun 30, 24 | 0.00 Decreased by N/A% | -8.39 M Decreased by -479.34% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | -2.68 M Decreased by -119.24% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | 37.57 K Increased by +N/A% | -2.20 M Decreased by -83.37% | Decreased by -5.86 K% Decreased by N/A% |
| Sep 30, 23 | 0.00 Decreased by N/A% | -2.63 M Decreased by -130.15% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -1.45 M Increased by +19.94% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | 13.94 M Increased by +461.06% | Increased by +N/A% Decreased by N/A% |
| Dec 31, 22 | 0.00 Decreased by N/A% | -1.20 M Increased by +68.88% | Decreased by N/A% Decreased by N/A% |